Idan Goren (@ibd_gorenmd) 's Twitter Profile
Idan Goren

@ibd_gorenmd

Gastroenterologist | Assistant Professor Medicine| SUNY Upstate Medical University

ID: 1301204784767270915

calendar_today02-09-2020 17:06:31

131 Tweet

696 Takipçi

494 Takip Edilen

Journal of Crohn's and Colitis (@jcc_ibd) 's Twitter Profile Photo

Peripheral Blood #Eosinophilia at Diagnosis of #IBD Is Associated with Severe Disease Course; A Nationwide Study From the epi-IIRN Cohort. Yerushalmy-Feler et al. iris dotan Idan Goren academic.oup.com/ecco-jcc/advan…

Peripheral Blood #Eosinophilia at Diagnosis of #IBD Is Associated with Severe Disease Course; A Nationwide Study From the epi-IIRN Cohort. Yerushalmy-Feler et al. <a href="/Iris_Dotan/">iris dotan</a> <a href="/IBD_GorenMD/">Idan Goren</a> academic.oup.com/ecco-jcc/advan…
Malcolm Tan (@ibdgastrodocsg) 's Twitter Profile Photo

Should steroids be used with upadacitinib during induction in UC? - post-hoc analysis suggests not - no impact on weeks 8 & 52 outcomes (Adapted Mayo Score) - steroid use a/w serious infections

Should steroids be used with upadacitinib during induction in UC? 

- post-hoc analysis suggests not
- no impact on weeks 8 &amp; 52 outcomes (Adapted Mayo Score)
- steroid use a/w serious infections
Dr Mark Silverberg (@guthealthmd) 's Twitter Profile Photo

Extremely important elephant in the room in clinical trial design. The rate of steroid use is much higher in patients entering screening for and randomization for trials than in clinical practice. Why? Long washout periods. And placebo arms. Patients and their physicians have no

Idan Goren (@ibd_gorenmd) 's Twitter Profile Photo

#Elderly #IBD patients w/ CDI seen as high-risk for complications. 🌍 Study: 654 patients, multicenter cohort. 📊 CDI not linked to post-discharge IBD complications/mortality up to 1 year post-discharge. Journal of Crohn's and Colitis Y-ECCO Henit Yanai academic.oup.com/ecco-jcc/advan…

Jean-Frederic Colombel (@jeanfredericco1) 's Twitter Profile Photo

Anti-integrin αvβ6 autoantibodies are increased in PSC patients with concomitant IBD and correlate with liver disea… pubmed.ncbi.nlm.nih.gov/39490950/

Jan Král (@kraljan) 's Twitter Profile Photo

🚨 New #IBD Study 🚨 🌟 Vedolizumab & Ustekinumab in Pregnancy: Safe Options for IBD Moms-to-Be? 🌟 🔗📘tinyurl.com/2e5tzvud 📊 Background Outcomes of vedolizumab, ustekinumab, and anti-TNFs in pregnant women with IBD (EPI-MERES, 2014–2021). #GiTwitter #MedTwitter #MedEd

🚨 New #IBD Study 🚨

🌟 Vedolizumab &amp; Ustekinumab in Pregnancy: Safe Options for IBD Moms-to-Be? 🌟

🔗📘tinyurl.com/2e5tzvud

📊 Background
Outcomes of vedolizumab, ustekinumab, and anti-TNFs in pregnant women with IBD (EPI-MERES, 2014–2021).

#GiTwitter #MedTwitter #MedEd
GutMicrobiota Health (@gmfhx) 's Twitter Profile Photo

We're getting closer to the development and validation of an integrative risk score for the future risk of Crohn's disease in healthy first-degree relatives .Sun-Ho Lee MD PhD & colleagues provide new clues: gastrojournal.org/article/S0016-…

Shomron Ben-Horin (@shomronh) 's Twitter Profile Photo

Fascinating data from Eran Elinav lab in Cell : Metaproteomics of stool reveals 3% of content is not host nor microbiome but ingested protein, enabling to accurately identfy patterns of #diet cell.com/cell/abstract/…

Shomron Ben-Horin (@shomronh) 's Twitter Profile Photo

Our RCT now in Gastroenterology : Pts with #Crohn in remission, who recieved treat-to-target Tx guided by #capsule endoscopy inflammatory assessment, had a significantly lower flare risk over 24m compared to pts continuing standard care Helmsley Charitable Trust gastrojournal.org/article/S0016-…

Our RCT now in  <a href="/AGA_Gastro/">Gastroenterology</a>   : Pts with #Crohn in remission, who recieved treat-to-target Tx guided by #capsule endoscopy inflammatory assessment, had a significantly lower flare risk over 24m compared to pts continuing standard care 
<a href="/HelmsleyTrust/">Helmsley Charitable Trust</a>   
gastrojournal.org/article/S0016-…
Harry Sokol (@h_sokol) 's Twitter Profile Photo

Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…

Gastroenterology (@aga_gastro) 's Twitter Profile Photo

✨ The May Editor's Essential Reading examines mechanistic implications of the #MediterraneanDiet in patients with newly diagnosed #CrohnsDisease. Read the full article here ➡️ ow.ly/UqPo50VEJV5

✨ The May Editor's Essential Reading examines mechanistic implications of the #MediterraneanDiet in patients with newly diagnosed #CrohnsDisease. Read the full article here ➡️ ow.ly/UqPo50VEJV5